The challenges of organising cervical screening programmes in the 15 old member states of the European Union

This publication has 60 references indexed in Scilit:

• What’s next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination
  European Journal Of Cancer, 2009
• Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis
  BMJ, 2008
• Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
  Vaccine, 2008
• Do women ⩾50 years of age need as much screening as women <50 years after they have had negative screening results?
  British Journal of Cancer, 2008
• Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study
  BMJ, 2007
• Does HPV-status 6–12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence?
  European Journal Of Cancer, 2007
• Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses
  Vaccine, 2006
• Cervical cancer screening programmes and policies in 18 European countries
  British Journal of Cancer, 2004
• The cervical cancer epidemic that screening has prevented in the UK
  The Lancet, 2004
• Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients
  British Journal of Cancer, 2003